 Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces the appointment of Stefan Lutz, Ph.D. as Senior Vice President, Research and Karl A. Schoene, Ph.D. as Senior Vice President, Development Operations, effective immediately. Both positions are newly created and both report to Codexis President and CEO John Nicols. 